Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,051.6
-11.6 (-0.38%)

 

  • STI Straits Times Index
    3,051.6
    -11.6 (-0.38%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.3
    -3.2 (-0.21%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,099.1
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,595.1
    -18.8 (-0.52%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,826.6
    -13.1 (-0.04%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,060.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 355.0M
  • Value: 288.7M
  • Rise: 101
  • Fall: 89
  • Unch: 565

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.082-0.003
Asian Micro0.008+0.001
Aspen0.156+0.030
Hatten Land0.068-0.001
China Star Food0.029+0.005
VCPlus0.028-
YZJ Shipbldg SGD1.400-0.030
Biolidics0.230-0.005
CapLand IntCom T2.070+0.020
China Env Res0.013+0.002

World Indices

World Indices
Name Last Change
Nasdaq 14,746.4 +32.5
HSI 24,099.1
HSCEI 8,638.5
Jakarta 6,060.3 -0.5
Nikkei 225 29,819.6 -20.1
SSE Comp 3,593.4 -20.5
Shanghai A 3,766.1 -21.6
Shanghai B 273.4 +0.3
KOSPI 3,130.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PDS BIOTECHNOLOGY CORPORATION PDS BIOTECHNOLOGY CORPORATION
Updated on 21 Sep 2021 (End of trading day)
Last (USD): 14.960 Change: +0.200 High: 15.140 Remarks: -
Change (%): +1.36 Low: 14.680
Open 14.760 Yesterday's Close 14.760000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 236,391 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.52236 Trailing EPS (USD) e -0.40706 NAV (USD) b 2.5680
PE a - Trailing PE f - Price / NAV b 5.8255
Dividend (USD) d - Cash In Hand (USD) g 2.6298 Issued & Paid-up Shares c 28,423,900
Dividend Yield (%) d - Price / Cash In Hand g 5.689 Treasury Shares h -
Market Cap (M) 425.222 Enterprise Value (M) 351.026
Piotroski F Score 1 Exchange Code PDSB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 123.16 Free Float (%) 82.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 16 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Mar 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PDS BIOTECHNOLOGY CORPORATION NASDAQ 425.222 - - 5.8255 -
Industry Pharmaceuticals: Major NASDAQ 2,343.913 87.059 91.614 3.3466 1.400
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 183,200.114 57.322 48.581 11.6867 1.963
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 121,848.565 8.680 17.595 1.6248 2.773
Local Peer ROYALTY PHARMA PLC NASDAQ 22,240.710 22.810 22.893 3.8789 0.524
Local Peer REPLIGEN CORP NASDAQ 17,272.737 288.233 172.843 10.7748 -
Local Peer VIATRIS INC NASDAQ 16,059.371 - - 0.7573 -
Local Peer CUREVAC NV NASDAQ 9,979.530 - - - -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 8,996.157 - - 11.0343 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 6,600.291 - - 6.7022 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,591.723 - - 19.3929 -
Local Peer ALLAKOS INC NASDAQ 5,831.622 - - 10.2132 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,670.604 83.114 83.114 6.5903 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,628.199 - - 19.1511 -
Other Local Peers GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), ERASCA INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), GENERATION BIO CO (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), KRONOS BIO INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), ICOSAVAX INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), GH RESEARCH PLC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), ANNEXON INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PHARVARIS NV (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), BEYONDSPRING INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), AC IMMUNE SA (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), CLENE INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), 89BIO INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), ESSA PHARMA INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NEXIMMUNE INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), DURECT CORP (NASDAQ), INOZYME PHARMA INC (NASDAQ), XOMA CORP (NASDAQ), OBSEVA SA (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), HARROW HEALTH INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), IMMUNIC INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), TRICIDA INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ALZAMEND NEURO INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), NOVAN INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), POLYPID LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EYENOVIA INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), GALECTO INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), RENOVORX INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), MANNATECH INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), SEQLL INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), PAINREFORM LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 433,121.934 29.436 24.378 6.2248 2.419
Global Peer PFIZER INC NYSE 246,245.825 25.608 18.615 3.5157 3.459
Global Peer ELI LILLY AND COMPANY NYSE 220,176.249 35.548 36.269 34.1656 1.286
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 202,178.581 24.898 22.479 3.7411 2.321
Global Peer ABBVIE INC NYSE 189,353.337 41.561 28.738 15.0650 4.512
Global Peer MERCK & CO INC NYSE 182,182.699 25.779 32.702 5.4719 3.444
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 180,393.431 27.995 25.340 17.2541 1.322
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 134,059.896 - - 3.6421 3.080
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 98,320.200 13.337 16.577 4.6285 5.295
Global Peer WUXI APPTEC HKEx 534,219.675 160.960 115.360 12.1010 0.195
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), SINOPHARM (HKEx), HUTCHMED (HKEx), REMEGEN-B (HKEx), SH PHARMA (HKEx), JUNSHI BIO (HKEx), CMS (HKEx), HYGEIA HEALTH (HKEx), AKESO-B (HKEx), BAIYUNSHAN PH (HKEx), INNOCARE-B (HKEx), CARSGEN-B (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), SIMCERE PHARMA (HKEx), EVEREST MED-B (HKEx), TRAD CHI MED (HKEx), ADC THERAPEUTICS SA (NYSE), CSTONE PHARMA-B (HKEx), HENLIUS (HKEx), SSY GROUP (HKEx), OCUMENSION-B (HKEx), ZYMEWORKS INC (NYSE), HEPALINK (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), UNITED LAB (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), IMMUNOTECH-B (HKEx), TONGRENTANGCM (HKEx), Kimia Farma Tbk. (IDX), SCICLONE PHARMA (HKEx), ANTENGENE-B (HKEx), CKLIFE SCIENCES (HKEx), SHINEWAY PHARM (HKEx), HUA MEDICINE-B (HKEx), ZHAOKE OPHTH-B (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), CYBIN INC (NYSE American), TOT BIOPHARM-B (HKEx), PYC THERAPEUTICS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), DAWNRAYS PHARMA (HKEx), BSTEAD (Bursa), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARM (HKEx), IP (SET), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), IX Biopharma (SGX), LANNETT CO INC (NYSE), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), NOXOPHARM LTD (ASX), SANAI HEALTH GP (HKEx), CRESO PHARMA LTD (ASX), KOTRA (Bursa), CHARMACY PHAR (HKEx), NEW RAY MEDIC (HKEx), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), NOVA (Bursa), Hyphens Pharma (SGX), BIOHLDG (Bursa), INVION LTD (ASX), MODERN CHI MED (HKEx), WAI YUEN TONG (HKEx), EXOPHARM LTD (ASX), NEP INTERLONG (HKEx), PHARMAXIS (ASX), PURAPHARM (HKEx), MEDLAB CLINICAL LIMITED (ASX), AGEX THERAPEUTICS INC (NYSE American), EXTRAWELL PHAR (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), JCT (SET), PALLA PHARMA LTD (ASX), SUNZEN (Bursa), IMMURON LIMITED (ASX), ACRUX (ASX), ONCOSIL MEDICAL LIMITED (ASX), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), SUDA PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.440
+3.03 %
10 Days --0.710
-4.53 %
20 Days -+2.510
+20.16 %
Medium Term Return 3 Months -+4.270
+39.94 %
6 Months -+9.970
+199.80 %
1 Year -+12.290
+460.30 %
Long Term Return 2 Years -+9.700
+184.41 %
Annualised Return Annualised --
+68.64 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.870 - 16.380 Change From 1 Year Low +13.090 % Change From 1 Year Low (%) +700.00
Change From 1 Year High -1.420 % Change From 1 Year High (%) -8.67
2 Years Range 0.615 - 16.380 Change From 2 Years Low